HEALTHWTOP DC
Federal judge in Virginia says certain abortion drug restrictions are unlawful
A federal judge in Virginia ruled that the FDA's 2023 restrictions on mifepristone, a drug used to terminate early pregnancies, are unlawful due to insufficient justification. The ruling follows similar challenges from abortion providers in Kansas, Montana, and Virginia, who argued the restrictions—requiring special certifications and risk acknowledgment forms—are excessive and medically unnecessary.
Mentioned
Related Signal
Adjacent reporting
- Federal judge in Virginia says certain abortion drug restrictions are unlawful
- Federal judge says certain abortion drug restrictions are unlawful
- Judge rules FDA restrictions on mifepristone are arbitrary and capricious
- Court restricts abortion access across the US by blocking the mailing of mifepristone
- US court limits mail-order access to abortion pill mifepristone